Molecular Biology Program
The Mark Ptashne Lab
We study basic mechanisms of gene regulation, primarily in yeast at the moment, but with an eye to understanding many basic aspects of biological regulation.
Narayan, S., Bryant., G.O., Shah, S., Berrozpe, G., Ptashne, M. (2017) OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts. Cell Reports. 20 (7):1585-1596. PubMed
Berrozpe, G., Bryant, G.O., Warpinski, K., Spagna, D., Narayan, S., Shah, S., Ptashne, M. (2017) Polycomb Responds to Low Levels of Transcription. Cell Reports. 20(4):785-793.
Wang, X., Ptashne, M. (2015) Nucleosome avidities and transcriptional silencing in yeast. Current Biology 25 , 1215-1220.
Ptashne, M. (2014) Reflections: The Chemistry of Gene Regulation. Journal of Biological Chemistry 289, 5417-5435.
Mark S. Ptashne, PhD
Virginia and Daniel K. Ludwig Chair
- Molecular biologist Mark Ptashne studies mechanisms of gene regulation.
- PhD, Harvard University
- [email protected]
- Email Address
- Office Phone
- Download CV
- PDF File
- Lab Phone
Get in Touch
Lab Head Email
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Mark S. Ptashne discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].